RE-1 Papaverine 30 mg/mL Phentolamine 3 mg/mL Alprostadil 200 mcg/mL
Lack of assurance of sterility.
437 recalls, newest first
Lack of assurance of sterility.
Lack of assurance of sterility.
cGMP deviations
cGMP deviations
cGMP deviations
TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions
TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.
TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.
CGMP Deviations: Failure to properly investigate failed microbial testing.
CGMP Deviations: Failure to properly investigate failed microbial testing.
CGMP Deviations: Failure to properly investigate failed microbial testing.
Microbial Contamination of Non-Sterile Products
Microbial Contamination of Non-Sterile Products
Microbial Contamination of Non-Sterile Product: Product is contaminated with Burkholderia gladioli.
Labeling Not Elsewhere Classified: Hand sanitizer packaged in containers resembling drinking water bottles.
Temperature Abuse; temperature excursion during shipping
Labeling: Label Error on Declared Strength; Bottles labeled as Methocarbamol 500 mg Tablets actually contain Methocarbamol 750 mg Tablets
CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.
CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.
CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.
Marketed without an approved NDA/ANDA: Product found to be tainted with Tadalafil.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Presence of Foreign Tablets/Capsules
Cross contamination: the excipient was found to be contaminated with theophylline.